首页 | 本学科首页   官方微博 | 高级检索  
     

缺血后处理对缺血-再灌注心肌的保护作用及其与线粒体ATP敏感性钾通道的关系
引用本文:任静华,陈玉培. 缺血后处理对缺血-再灌注心肌的保护作用及其与线粒体ATP敏感性钾通道的关系[J]. 中国胸心血管外科临床杂志, 2009, 16(6): 466-471
作者姓名:任静华  陈玉培
作者单位:重庆医科大学附属第二医院,麻醉科,重庆,400010
基金项目:重庆医科大学创新科研基金资助项目 
摘    要:目的探讨缺血后处理(IPo)的心肌保护作用及与心肌线粒体三磷酸腺苷(ATP)敏感性钾通道(mitoKATP)的关系,为药物后处理的研发提供依据。方法40只Wistar大鼠,建立大鼠离体心脏Langendorff灌注模型,采用随机数字表法分为5组,每组8只,正常对照组(NC组):用K-H液持续灌注100min,不做任何处理;缺血-再灌注(I/R)组:全心缺血40min,再灌注60min;IPo组:全心缺血40min,再灌注10s,缺血10s,反复6次,然后持续再灌注58min;5-羟基癸酸(5-HD)组:全心缺血40min后,先用含5-HD(100μmol/L)的K-H液再灌注15min,再用不含5-HD的K-H液再灌注45min;IPo+5-HD组:全心缺血40min后,先用含5-HD(100μmol/L)的K-H液再灌注10s,缺血10s,反复6次,再用含5-HD的K-H液持续灌注13min,然后用不含5-HD的K-H液再灌注45min。观察比较各组心功能、冠状动脉流量(CF)、冠状动脉流出液中心肌肌钙蛋白I(cTnI)含量、心肌梗死(AMI)面积和心肌细胞超微结构改变。结果再灌注末IPo组左心室发展压(74.3±3.3mmHgvs.57.1±3.3mmHg,t=13.00,P=0.000)、+dp/dtmax(1706.6±135.6mmHg/svs.1313.3±96.2mmHg/s,t=6.28,P=0.000)、-dp/dtmax(1132.8±112.1mmHg/svs.575.7±67.7mmHg/s,t=13.48,P=0.000)、CF(6.49±0.30ml/minvs.3.70±0.24ml/min,t=28.60,P=0.000)与I/R组比较均升高;左心室舒张期末内压(10.9±1.7mmHgvs.26.2±1.5mmHg,t=-19.21,P=0.000),冠状动脉流出液中cTnI含量(0.62±0.01ng/mlvs.0.71±0.01ng/ml,t=-12.00,P=0.000)均降低,AMI面积与I/R组比较减少20.8%(P〈0.05)。IPo+5-HD组对心肌的保护作用与IPo组相似,但作用轻于IPo组。电子显微镜观察结果表明,IPo和IPo+5-HD可减轻I/R引起的心肌纤维和线粒体损伤。结论IPo对I/R心肌有保护作用,其作用与mitoKATP的激活有关。

关 键 词:缺血后处理  心肌保护  缺血-再灌注损伤  线粒体三磷酸腺苷敏感性钾通道

The Protective Effects of Ischemic Post-conditioning on Ischemia-reperfusion Myocardium and the Relationship with Mitochondrial Adenosine Triphosphate Sensitive K+ Channels
REN Jing-hua,CHEN Yu-pei. The Protective Effects of Ischemic Post-conditioning on Ischemia-reperfusion Myocardium and the Relationship with Mitochondrial Adenosine Triphosphate Sensitive K+ Channels[J]. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2009, 16(6): 466-471
Authors:REN Jing-hua  CHEN Yu-pei
Affiliation:. (Department of Anesthesiology, Affiliated Second Hospital, Chongqing University of Medical Science, Chongqing 400010, P.R. China )
Abstract:Objective To investigate the protective effects of ischemic post-conditioning (IPo) on ischemia-reperfusion (I/R) myocardium and the relationship with mitochondrial adenosine triphosphate (ATP) sensitive K^+ channels (mitoKATP) and provide evidences to the development of drug-induced post-conditioning. Methods Langendorff models were established in 40 Wistar rats which were divided into 5 groups by random number table with 8 rats in each group. Normal control group(NC group):the rat hearts were continuously reperfused by Krebs-Henseleit bicarbonate buffer (K-HB) for 100 min without any other treatment; I/R group:the rat hearts underwent a 40-min global ischemia followed by a 60-min reperfusion; IPo group:after a 40-min global ischemia,the process of 10-second reperfusion followed by a 10-second ischemia was repeated 6 times,then there was a continuous 58-min reperfusion; 5-hydroxydecanoic acid(5-HD) group:after a 40-min global ischemia,hearts with 5-HD(100 μmol/L) K-HB were reperfused for 15-min and then perfused without 5-HD for 45-min;IPo+5-HD group:after a 40-min global ischemia,the process that the isolated hearts with 5-HD(100 μmol/L) K-HB were reperfused for 10-second followed by a 10-second ischemia was repeated 6 times,then the hearts with 5-HD(100 μmol/L) K-HB were continuously perfused for 13-min followed by reperfusion without 5-HD(100 μmol/L) K-HB for 45-min. The cardiac function,coronary flow(CF),cardiac troponin I(cTnI) content in coronary effluent,the area of acute myocardial infarction (AMI) and myocardial ultrastructure were observed. Results Left ventricular developed pressure(74.3±3.3 mm Hg vs. 57.1±3.3 mm Hg,t=13.00,P=0.000),+dp/dtmax(1 706.6±135.6 mm Hg/s vs. 1 313.3±96.2 mm Hg/s,t=6.28,P=0.000),-dp/dtmax(1 132.8±112.1 mm Hg/s vs. 575.7±67.7 mm Hg/s,t=13.48,P=0.000) and CF(6.49±0.30 ml/min vs. 3.70±0.24 ml/min,t=28.6,P=0.000) in IPo group were higher than those in I/R group. Left ventricular en
Keywords:Ischemic post-conditioning  Myocardial protection  Ischemia-reperfusion injury  Mitochondrial adenosine triphosphate sensitive K^+ channel
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号